Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gladstone Inst. of Virology & Immunology
Future of HIV therapeutics is brightening, says expert
September 24th, 2004
Recent discoveries about the way that HIV infects cells are propelling the development of a broad spectrum of promising new antiviral drugs, according to an invited commentary on the topic. The assessment was made by Gladstone Institute of Virology and Immunology (GIVI) Director Warner Greene, MD, PhD, who also serves as professor of medicine, microbiology and immunology at the University of California, San Francisco. In the piece, in September 2004 Nature Immunology, Greene pointed out that basic research on HIV, a relatively simple pathogen with only nine genes encoding 15 proteins, is leading to compelling new therapies that deny the...
Source: Food & Drug Law Weekly (2004-09-24)
|
